Immune intervention with anti-CD3 in diabetes

Nature Medicine

Volumn 11, Issue 7, 2005, Pages 716-718

  Harlan, David M ^a   Von Herrath, Matthias ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CD3 ANTIGEN; INSULIN;

ANTIBODY SPECIFICITY; CELL PROLIFERATION; ENVIRONMENTAL FACTOR; GLUCOSE BLOOD LEVEL; HEREDITY; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; PANCREAS CELL; PRIORITY JOURNAL; PROPHYLAXIS; SHORT SURVEY;

ANTIBODIES; ANTIGENS, CD3; CLINICAL TRIALS, PHASE II; DIABETES MELLITUS, TYPE 1; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOTHERAPY; INSULIN; ISLETS OF LANGERHANS; PREDIABETIC STATE;

EID: 22544478744     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0705-716     Document Type: Short Survey

References (17)

1. The Canadian-European Randomized Control Trial Group. Diabetes 37, 1574-1582 (1988).
2. Rother, K.I. & Harlan, D.M. J. Clin. Invest. 114, 877-883 (2004).
3. Herold, K.C. et al. N. Engl. J. Med. 346, 1692-1698 (2002).
4. Chatenoud, L. et al. N. Engl. J. Med. 352, 2598-2608 (2005).
5. Sutherland, D.E. et al. Trans. Assoc. Am. Physicians 97, 80-87 (1984).
6. Chatenoud, L., Thervet, E., Primo, J. & Bach, J.F. Proc. Natl. Acad. Sci. USA 91, 123-127 (1994).
7. Herald, K.C. et al. Diabetes 54, 1763-1769 (2005).
8. The Diabetes Control and Complications Trial Research Group. Ann. Intern. Med. 128, 517-523 (1998).
9. Swinnen, L.J. et al. N. Engl. J. Med. 323, 1723-1728 (1990).
10. Smith, J.A., Tso, J.Y., Clark, M.R., Cole, M.S. & Bluestone, J.A. J. Exp. Med. 185, 1413-1422 (1997).
11. Smith, J.A., Tang, Q. & Bluestone, J.A. J. Immunol. 160, 4841-4849 (1998).
12. Walker, M.R. et al. J. Clin. Invest. 112, 1437-1443 (2003).
13. Homann, D. et al. Immunity 11, 463-472 (1999).
14. Skyler, J.S. et al. Diabetes Care 28, 1068-1076 (2005).
15. Nakayama, M. et al. Nature 435, 220-223 (2005).
16. von Herrath, M.G. & Harrison, L.C. Nat. Rev. Immunol. 3, 223-232 (2003).
17. Harlan, D.M. Endocrinology 145, 463-466 (2004).